BDBM412525 US10399972, Example 16::[3-fluoro-8-(6-oxa-2- azaspiro[3.5]non-2-yl)-5,11- dihydro-6H-pyrido[2,3- b][1,5]benzodiazepin-6-yl][trans- 4-(propan-2- yloxy)cyclohexyl]methanone

SMILES CC(C)O[C@H]1CC[C@@H](CC1)C(=O)N1Cc2cc(F)cnc2Nc2ccc(cc12)N1CC2(C1)CCCOC2

InChI Key InChIKey=KLLFVCBDILTEHS-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 412525   

TargetIsocitrate dehydrogenase [NADP] cytoplasmic [R132H](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM412525(US10399972, Example 16 | [3-fluoro-8-(6-oxa-2- aza...)
Affinity DataIC50: 24nMAssay Description:Each test compound (10 mM stock in DMSO) is diluted in DMSO to make a 10-point, 3-fold dilution series. 125 nL of each dilution or DMSO alone is disp...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent